Clinical Trial Update: Effect of the Molecular Weight of Oat β-glucan on Its Ability to Lower Serum Cholesterol [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigates whether the molecular weight of oat beta-glucan influences its ability to lower serum cholesterol in individuals with hype…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Oat beta-glucan (beta-glucan from oats)

Snippet

Sponsor: Glycemic Index Laboratories, Inc | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED